ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data…
14 October 2025 - The International Olympic Committee (IOC) and the World Olympians Association (WOA) will further increase their joint support for Olympians.…
APIA, Samoa, Oct. 11, 2025 /PRNewswire/ -- Phemex, the most efficient crypto exchange, today announced the launch of its Market…
06 October 2025 - Athletes competing at the Milano Cortina 2026 Olympic Winter Games can expect the same high level of mental health…
30 September 2025 - A total of 15 organisations and individuals today joined the Grassroots365 Innovation Incubation initiative, which is…
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…
September 26, 2025 16:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE…
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- CLO Virtual Fashion, a global leader in digital garment simulation and the creator…
NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an…
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…